IVERIC BIO INC's ticker is ISEE and the CUSIP is 46583P102. A total of 104 filers reported holding IVERIC BIO INC in Q3 2020. The put-call ratio across all filers is 0.39 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $100,014,043 | +747.9% | 2,542,299 | +424.4% | 0.52% | +698.5% |
| Q1 2023 | $11,795,160 | -62.3% | 484,799 | -66.8% | 0.06% | -65.2% |
| Q4 2022 | $31,301,420 | +32.5% | 1,462,000 | +11.0% | 0.19% | +42.7% |
| Q3 2022 | $23,627,000 | +353.1% | 1,317,000 | +74.5% | 0.13% | +322.6% |
| Q4 2020 | $5,215,000 | +22.5% | 754,740 | 0.0% | 0.03% | +6.9% |
| Q3 2020 | $4,257,000 | +11.3% | 754,740 | +0.6% | 0.03% | -6.5% |
| Q2 2020 | $3,825,000 | – | 750,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TCG Crossover Management, LLC | 2,516,920 | $42,360,000 | 17.00% |
| COMMODORE CAPITAL LP | 2,214,961 | $37,278,000 | 8.33% |
| Ally Bridge Group (NY) LLC | 650,000 | $10,940,000 | 8.11% |
| Vivo Capital, LLC | 6,431,940 | $108,250,000 | 7.45% |
| Samsara BioCapital, LLC | 1,262,551 | $21,249,000 | 5.35% |
| Deep Track Capital, LP | 4,500,000 | $75,735,000 | 4.86% |
| ACUTA CAPITAL PARTNERS, LLC | 539,500 | $9,080,000 | 4.24% |
| Paradigm Biocapital Advisors LP | 910,416 | $15,322,000 | 4.05% |
| Logos Global Management LP | 1,800,000 | $30,294,000 | 3.93% |
| Yiheng Capital Management, L.P. | 5,058,585 | $85,136,000 | 3.89% |